Michael D. Miller

The Hepatitis B Virus Polymerase Mutation rtV173L Is Selected during Lamivudine Therapy and Enhances Viral Replication In Vitro

William E. Delaney, Huiling Yang, Christopher Westland et al. · Journal of Virology · 2003 · 259 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1 1Gilead Sciences gratefully acknowledges the patients, investigators, and study site personnel who participated in clinical trials GS-98-437 and GS-98-438.

C. Westland, William E. Delaney, Huiling Yang et al. · Gastroenterology · 2003 · 223 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials

Evguenia S. Svarovskaia, Hadas Dvory‐Sobol, Neil Parkin et al. · Clinical Infectious Diseases · 2014 · 216 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys

Yasuhiro Yasutomi, Keith A. Reimann, Carol I. Lord et al. · Journal of Virology · 1993 · 214 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

<i>In Vitro</i> Susceptibility of Adefovir-Associated Hepatitis B Virus Polymerase Mutations to other Antiviral Agents

Xiaoping Qi, Shelly Xiong, Huiling Yang et al. · Antiviral Therapy · 2007 · 178 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17